LINK ALTERNATIF MBL77 Options
Not all patients with CLL require therapy. In spite of all recent innovations, the iwCLL nevertheless suggests watchful observation for clients with asymptomatic ailment.86 This recommendation is predicated on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR